ArriVent BioPharma Reports Second Quarter 2024 Financial Results

Go back to ArriVent BioPharma Reports Second Quarter 2024 Financial Results
(NASDAQ: AVBP) Delayed: 29.12 -0.06 (0.21%)
Previous Close $29.18    52 Week High
Open $29.45    52 Week Low
Day High $29.77    P/E N/A 
Day Low $28.95    EPS
Volume 304,811       

(NASDAQ: IMCR) Delayed: 36.88 +0.60 (1.65%)
Previous Close $36.28    52 Week High
Open $36.70    52 Week Low
Day High $36.98    P/E N/A 
Day Low $35.68    EPS
Volume 329,451